Condition
HPV clinical trials and research
As of November 12, 2026, Find a Trial lists 34 HPV clinical trials that are recruiting, at sites in 16 countries (most in United States (14), Czechia (2), Kenya (2)). By phase: Phase 2 (3), Phase 4 (3), Early Phase 1 (1). The most active sponsors are Fred Hutchinson Cancer Center (4), General University Hospital, Prague (2), Memorial Sloan Kettering Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 34Clinical trials
- 16Countries
Newest HPV clinical trials
All recruiting trials (34)
-
Can people collect their own vaginal sample for HPV testing as well as clinician collection for comparison?
This study tests whether individuals can correctly use a self-collection device to gather a vaginal sample for high-risk HPV screening and whether the self-collected sample agrees with clinician-collected samples.
-
Two-probe thermal ablation for cervical precancer in WLWH in South Africa
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.
-
Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe
This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.
-
Digital tools to boost HPV vaccination intentions among Nigerian caregivers
This study tests whether different online content can help Nigerian parents of unvaccinated girls ages 9-14 decide to vaccinate their daughters against HPV.
-
HPV monitoring after chemoradiotherapy for cervical cancer
This project will test whether HPV detected on cervical swabs and in blood can find cancer recurrence in people with stage IB–IVA cervical cancer after curative chemoradiotherapy.
-
Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya
This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.
-
Self-swab versus clinician-collected HPV screening for vulnerable women in Reunion
This study tests whether self-collected swabs work as well and feel as acceptable as clinician-collected swabs for HPV screening in vulnerable women aged 30–65.
-
Two-probe thermal ablation for cervical precancer in WLWH in Rwanda
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in Rwanda.
-
Self-sampling HPV screening offered in the emergency department
This project tests whether offering HPV self-sampling in the emergency department helps more people aged 30–65 with a cervix get screened for cervical cancer.
-
CHW4CervixHealth: HPV self-collection kits with community health workers
This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.
-
Q-Pad menstrual-pad test to detect high-risk HPV and cervical precancer
This study tests whether a home menstrual-pad kit (Q-Pad) can detect high-risk HPV and cervical precancer in people referred for colposcopy after an abnormal Pap or HPV result.
-
How menstrual cups, tampons, and pads affect vaginal microbiota and immunity
This project will see if using menstrual cups, tampons, or pads is linked to changes in vaginal bacteria, local immune responses, or recurrence of common vaginal infections in adult women.
-
Adaptive pre-surgery treatment for untreated HPV‑negative locoregional head and neck cancer
This trial will test whether giving volrustomig with paclitaxel and carboplatin before standard therapy can shrink tumors in adults with untreated, locally advanced HPV‑negative head and neck squamous cell carcinoma.
-
Anal cancer screening for men on PrEP
This study will test how well anal swabs and DNA methylation testing find high-grade anal lesions (HSIL) and how common those lesions are in men who have sex with men using PrEP, and whether HSIL affects quality of life.
-
Papillex® for abnormal cervical cells caused by HPV
This trial will see if taking Papillex® for 180 days helps abnormal cervical cells caused by HPV improve in women aged 25–55 with CIN 1 or 2.
-
Reducing treatment intensity for HPV-positive oropharyngeal cancer
This study is testing if lowering radiation doses and skipping chemotherapy can still help patients with HPV-positive throat cancer live longer and feel better while reducing side effects.
-
Investigating multiple HPV infections and their role in cervical changes
This study looks at how common multiple high-risk HPV infections are in people with abnormal cervical tests to see how they might affect cervical health.
-
One-dose HPV vaccine versus two- and three-dose schedules
This study will see if one dose of the HPV vaccine gives the same immune response as two or three doses in healthy adults aged 18 to 45.
-
HPV self-collection program for cervical cancer screening
This study tests a new program that lets women overdue for cervical cancer screening collect their own samples at home or in the clinic to see if it helps them get screened more easily and follow up on any positive HPV results.
-
Improving HPV vaccination rates through standing orders
This study tests if allowing healthcare team members to give HPV vaccines without needing a doctor's order can help more kids aged 11-12 get vaccinated.
-
Assessing regression of cervical precancerous lesions and risk factors
This study is testing how well certain treatments help women with severe cervical precancerous lesions get better and if there are specific factors that can predict their recovery.
-
Community-based strategy to improve cervical cancer screening access
This study is testing a new way for women in low-resource communities in Texas to get cervical cancer screenings using self-sample HPV testing with help from community health workers.
-
Adjuvant Gardasil 9 Vaccination for Women Treated for Vulvar HSIL
This study tests whether giving Gardasil 9 after treatment for vulvar HSIL can help prevent recurrence in women 18 and older.
-
Study of gut and vaginal microbiota in women living with HIV
This study looks at how the balance of bacteria in the vagina affects the risk of HPV infection and cervical issues in women living with HIV in China.
-
Using games to encourage vaccinations in children
This study tests if using fun games can help kids aged 11-14 feel more confident about getting their HPV and COVID-19 vaccines.
-
Treatment approaches for HPV-related lesions in women
This study looks at whether getting vaccinated after surgery for HPV-related lesions can help reduce the chances of women developing cervical dysplasia or cancer later on.
-
mSaada mobile app to support HPV-based cervical screening and follow-up
This project will test whether the mSaada mobile app helps community health volunteers in Kenya increase HPV screening and ensure women aged 30–65 get follow-up and treatment.
-
Reduced dosing of the HPV vaccine for women living with HIV
This study is testing if a lower dose of the HPV vaccine can effectively protect women living with HIV from HPV and cervical cancer.
-
Lower radiation therapy combined with standard chemotherapy for HPV-positive throat cancer
This study is testing whether using less radiation therapy along with standard chemotherapy can help people with HPV-positive throat cancer feel better while causing fewer side effects.
-
Using blood tests to determine treatment timing for HPV-related throat cancer
This study is testing if blood tests can help decide when to start treatment for people with HPV-related throat cancer after surgery, by checking their tumor DNA levels.
-
New HPV vaccine tested in healthy volunteers
This study is testing a new HPV vaccine in healthy adults aged 18-45 to see if it can safely boost their immune response against different types of HPV that can cause cancer.
-
Automated cervical cancer screening using a smartphone AI classifier
This study is testing a smartphone app that uses AI to help improve cervical cancer screening in low- and middle-income countries by making it more accurate and easier for healthcare providers.
-
Surgical removal of eye-surface squamous tumors in people living with HIV in Sub-Saharan Africa
We will try surgical removal of suspected eye-surface squamous tumors in people living with HIV in sub‑Saharan Africa and follow them for 12 months to see how surgery, tissue testing, and follow-up care work.
-
Understanding severe viral infections in patients without known immune issues
This study is trying to understand why some healthy people get severe viral infections and how different tests can help figure it out.
Related topics
Quick answers
How many HPV clinical trials are recruiting right now?
34, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (14 trials), Czechia (2 trials), Kenya (2 trials), Canada (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.